These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 24085772)

  • 21. Multisite effectiveness trials of treatments for substance abuse and co-occurring problems: have we chosen the best designs?
    Nunes EV; Ball S; Booth R; Brigham G; Calsyn DA; Carroll K; Feaster DJ; Hien D; Hubbard RL; Ling W; Petry NM; Rotrosen J; Selzer J; Stitzer M; Tross S; Wakim P; Winhusen T; Woody G
    J Subst Abuse Treat; 2010 Jun; 38 Suppl 1(Suppl 1):S97-112. PubMed ID: 20307801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics of available studies and dissemination of research using major clinical data sharing platforms.
    Vazquez E; Gouraud H; Naudet F; Gross CP; Krumholz HM; Ross JS; Wallach JD
    Clin Trials; 2021 Dec; 18(6):657-666. PubMed ID: 34407656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conducting research with racial/ethnic minorities: methodological lessons from the NIDA Clinical Trials Network.
    Burlew AK; Weekes JC; Montgomery L; Feaster DJ; Robbins MS; Rosa CL; Ruglass LM; Venner KL; Wu LT
    Am J Drug Alcohol Abuse; 2011 Sep; 37(5):324-32. PubMed ID: 21854274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The first decade of the National Drug Abuse Treatment Clinical Trials Network: bridging the gap between research and practice to improve drug abuse treatment.
    Tai B; Straus MM; Liu D; Sparenborg S; Jackson R; McCarty D
    J Subst Abuse Treat; 2010 Jun; 38 Suppl 1(Suppl 1):S4-13. PubMed ID: 20307794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sharing data from clinical trials: the rationale for a controlled access approach.
    Sydes MR; Johnson AL; Meredith SK; Rauchenberger M; South A; Parmar MK
    Trials; 2015 Mar; 16():104. PubMed ID: 25872927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study results from the Clinical Trials Network's first 10 years: where do they lead?
    Wells EA; Saxon AJ; Calsyn DA; Jackson TR; Donovan DM
    J Subst Abuse Treat; 2010 Jun; 38 Suppl 1(Suppl 1):S14-30. PubMed ID: 20307792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How practice and science are balanced and blended in the NIDA Clinical Trials Network: the bidirectional process in the development of the STAGE-12 protocol as an example.
    Donovan DM; Daley DC; Brigham GS; Hodgkins CC; Perl HI; Floyd AS
    Am J Drug Alcohol Abuse; 2011 Sep; 37(5):408-16. PubMed ID: 21854284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systematic archiving and access to health research data: rationale, current status and way forward.
    Rani M; Buckley BS
    Bull World Health Organ; 2012 Dec; 90(12):932-9. PubMed ID: 23284199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rates and influences of alcohol use disorder comorbidity among primary stimulant misusing treatment-seekers: meta-analytic findings across eight NIDA CTN trials.
    Hartzler B; Donovan DM; Huang Z
    Am J Drug Alcohol Abuse; 2011 Sep; 37(5):460-71. PubMed ID: 21854291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ten take home lessons from the first 10 years of the CTN and 10 recommendations for the future.
    Carroll KM; Ball SA; Jackson R; Martino S; Petry NM; Stitzer ML; Wells EA; Weiss RD
    Am J Drug Alcohol Abuse; 2011 Sep; 37(5):275-82. PubMed ID: 21854269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interventions for adults with a history of complex traumatic events: the INCiTE mixed-methods systematic review.
    Melton H; Meader N; Dale H; Wright K; Jones-Diette J; Temple M; Shah I; Lovell K; McMillan D; Churchill R; Barbui C; Gilbody S; Coventry P
    Health Technol Assess; 2020 Sep; 24(43):1-312. PubMed ID: 32924926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The NIDA clinical trials network: evolving, expanding, and addressing the opioid epidemic.
    Tai B; Dobbins R; Blackeney Q; Liu D; Moran L
    Addict Sci Clin Pract; 2021 May; 16(1):28. PubMed ID: 33964973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Data sharing: experience of accessing individual patient data from completed randomised controlled trials in vascular and cognitive medicine.
    Scutt P; Woodhouse LJ; Montgomery AA; Bath PM
    BMJ Open; 2020 Sep; 10(9):e038765. PubMed ID: 32912955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A systematic scoping review of research on Black participants in the National Drug Abuse Treatment Clinical Trials Network.
    Montgomery L; Burlew AK; Haeny AM; Jones CA
    Psychol Addict Behav; 2020 Feb; 34(1):117-127. PubMed ID: 31246072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LabKey Server: an open source platform for scientific data integration, analysis and collaboration.
    Nelson EK; Piehler B; Eckels J; Rauch A; Bellew M; Hussey P; Ramsay S; Nathe C; Lum K; Krouse K; Stearns D; Connolly B; Skillman T; Igra M
    BMC Bioinformatics; 2011 Mar; 12():71. PubMed ID: 21385461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relation of study design to recruitment and retention in CTN trials.
    Wakim PG; Rosa C; Kothari P; Michel ME
    Am J Drug Alcohol Abuse; 2011 Sep; 37(5):426-33. PubMed ID: 21854286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychological interventions to improve self-management of type 1 and type 2 diabetes: a systematic review.
    Winkley K; Upsher R; Stahl D; Pollard D; Kasera A; Brennan A; Heller S; Ismail K
    Health Technol Assess; 2020 Jun; 24(28):1-232. PubMed ID: 32568666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An interactive website to aid young women's choice of contraception: feasibility and efficacy RCT.
    Stephenson J; Bailey JV; Blandford A; Brima N; Copas A; D'Souza P; Gubijev A; Hunter R; Shawe J; Rait G; Oliver S
    Health Technol Assess; 2020 Nov; 24(56):1-44. PubMed ID: 33164729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized controlled trial of a collaborative care intervention to manage cancer-related symptoms: lessons learned.
    Steel J; Geller DA; Tsung A; Marsh JW; Dew MA; Spring M; Grady J; Likumahuwa S; Dunlavy A; Youssef M; Antoni M; Butterfield LH; Schulz R; Day R; Helgeson V; Kim KH; Gamblin TC
    Clin Trials; 2011 Jun; 8(3):298-310. PubMed ID: 21730078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retention in the National Institute on Drug Abuse Clinical Trials Network Women and Trauma Study: implications for posttrial implementation.
    Pinto RM; Campbell AN; Hien DA; Yu G; Gorroochurn P
    Am J Orthopsychiatry; 2011 Apr; 81(2):211-7. PubMed ID: 21486263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.